SRY-box transcription factor 2 mRNA (SOX2 mRNA) (SOX2 mRNA)

SRY-box transcription factor 2 (SOX2) mRNA is the messenger RNA transcript of the SOX2 gene, which encodes a master transcription factor of the high-mobility group (HMG) box family (UniProt P48431). It plays a fundamental role in maintaining the pluripotency and self-renewal of embryonic stem cells and is essential for the maintenance of adult stem cell populations, particularly in the nervous system and various epithelia (NIH/PubMed). In many human cancers, including glioblastoma and squamous cell lung carcinoma, SOX2 mRNA is frequently overexpressed or amplified, driving tumor initiation, progression, and resistance to therapy by sustaining a cancer stem cell phenotype (NIH/PubMed). Because the SOX2 protein is considered "undruggable" due to its lack of a small-molecule binding pocket, the mRNA itself has become a key therapeutic target for RNA-targeted modalities such as small interfering RNAs (siRNAs) and antisense oligonucleotides (ASOs) (NIH/PubMed). Additionally, SOX2 mRNA is utilized in regenerative medicine as a reprogramming factor to generate induced pluripotent stem cells (iPSCs) (Wikipedia). Therapeutic development is currently focused on overcoming delivery barriers and ensuring specificity to avoid disrupting normal stem cell populations in tissues like the central nervous system (NIH/PubMed). Experimental drugs like EPD-301 and vaccines like STEMVAC are being explored to target SOX2-driven pathologies (Patsnap). Safety concerns primarily involve the risk of teratoma formation and the potential impairment of normal stem cell niches (NIH/PubMed).

Other names

SRY-box 2 mRNASRY-box transcription factor 2 transcriptSOX2 transcriptSex determining region Y-box 2 mRNA

RNA interference (siRNA), antisense inhibition (ASO), vaccine-mediated immunotherapy, and mRNA-mediated reprogramming.